The Leading CRO in Eastern Europe

Since 2005, we have conducted hundreds of clinical trials in Russia and all of Eastern Europe. Our full range of CRO services has helped sponsors worldwide in offshoring their clinical trials and bringing their innovative treatments to market.

Thorough local expertise

• 14+ years’ experience facilitating clinical trials in Russia and Europe
• Risk-management approach
• 300+ clinical studies in portfolio
• Team of 200+ clinical operations professionals

Global sponsors

• Extensive project portfolio with sponsors from EU, US, CIS and Asia
• Successfully passed more than 60 audits by sponsors with no significant findings

Record-setting patient enrollment

• Access to the network of 1600+ leading scientific sites
• Extensive experience in fast enrollment of patients with different indications
• Patient engagement solutions
• CRO site management services

Quality

• FDA/EMA acceptable data
• Compliance with the international standards (ICH GCP), local regulatory requirements and internal SOPs

News

all news

16

Aug

700 Patients Recruited for Ph3 Erectile Dysfunction Study for Futura Medical

OCT, Eastern Europe’s leading CRO, partners with UK-based Futura Medical; completes clinical trial enrolment for MED2002, a topical gel developed to treat erectile dysfunction.

read

FIRST PATIENTS HAVE BEEN ENROLLED IN TWO CLINICAL STUDIES IN HEMORRHOIDS

OCT has successfully initiated patient recruitment for the phase III clinical trials in hemorrhoids in Russia. Within the project OCT will be running two studies: one with the suppository therapy, and the other where the subjects will undergo a rectal cream treatment. As of now, first subjects have been enrolled in both trials. 

read

15

Jul

03

Jul

DIA Global Annual Meeting 2019 recap by OCT  

DIA is more than just a traditional meeting, the event has been a landmark, must-attend gathering for more than 50 years.  This year it became a meeting point for stakeholders from across the entire drug development spectrum, from discovery to marketed use, to facilitate open collaboration by incorporating representatives from the whole life sciences industry.

read

Enrollment target reached: 1030 patients for a phase III erectile dysfunction study in 4 countries

OCT team has successfully completed recruitment of 1030 subjects for a phase III study of a drug for male erectile dysfunction. The study is running in Russia, Bulgaria, Ukraine and Latvia.

read

27

Jun

Meet us

all events

11-13

November 2019

BIO-Europe Hamburg

Hamburg, Germany

18-19

September 2019

KoNECT International Conference

Conrad Seoul, South Korea

11-12

September 2019

BioPharm America 2019

Boston, USA

11

Nov

BIO-Europe Hamburg

Schedule a meeting with our Business Development team Polina Shatrova pshatrova@oct-clinicaltrials.com

18

Sep

KoNECT International Conference

Schedule a meeting with our Business Development team Olga Ivanova oivanova@oct-clinicaltrials.com

11

Sep

BioPharm America 2019

Schedule a meeting with our Business Development team Anna Yanaeva ayanaeva@oct-clinicaltrials.com

Send a request